Telotristat Etiprate - Expanded Treatment for Patients With Carcinoid Syndrome Symptoms
Clinical trial NCT02026063 · COMPLETED
Trial details
- NCT number
- NCT02026063
- Sponsor
- Lexicon Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-14
- Primary completion
- 2018-09-12
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.